Drug Type CAR-NK |
Synonyms CAR-natural killer cell therapy, taNK cells, Target-activated natural killer cells + [3] |
Target |
Action antagonists |
Mechanism HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists), T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Recurrent Glioblastoma | Phase 1 | Germany | 01 Dec 2017 | |
Bladder Cancer | Preclinical | United States | 16 Jul 2015 | |
Breast Cancer | Preclinical | United States | 16 Jul 2015 |
Not Applicable | 17 | NKIL15 | hdzvehcwzo(jmmnbdqzii) = sjsyywzeuc stdjondsko (edlxaaivhq ) View more | - | 21 May 2015 | ||
uuplqmbdsi(tmlsgrtbnb) = bhfxuxkudh cdjryaxvup (gtirlrblhr, 28 - 1547) View more |